News
-
-
-
-
PRESS RELEASE
Menarini Group and NewAmsterdam Pharma Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
Menarini Group and NewAmsterdam Pharma receive European Commission approval for Ubeslo and Evlarco, marking a milestone for cardiovascular disease treatment with LDL-C reduction therapies -
-
-
-
PRESS RELEASE
NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
NewAmsterdam Pharma and Menarini Group receive positive CHMP opinion recommending marketing authorization for Ubeslo and Evlarco in Europe. Milestone for cardiovascular disease treatment -
-
PRESS RELEASE
THIRTY YEARS TO REMEMBER: THE FAIR PLAY MENARINI AWARD SHINES AT THE TEATRO DEL MAGGIO MUSICALE FIORENTINO
The Fair Play Menarini International Award commemorates 30 years of honoring sports champions for their integrity and respect. Legends and rising stars celebrated at Teatro del Maggio Musicale Fiorentino